Nutreco co-led a $49.8m round for the mycoprotein ingredient developer and University of Strathclyde spinout that included Axa.
UK-based mycoprotein producer Enough raised €42m ($49.8m) today in a series B round co-led by animal nutrition specialist Nutreco and Olympic Investments, the private investment arm of the Onassis Foundation.
The round also featured Axa IM Alts, which is part of insurance group Axa and which invested through its Axa Impact Fund-Climate & Biodiversity vehicle, alongside HAL Investments and Tailored Solutions, Scottish Enterprise and CPT Capital, which remains Enough’s largest shareholder.
Enough produces alternative proteins and its core product is…
